Inovio Pharmaceuticals (INO)
NASDAQ:INO
Holding INO?
Track your performance easily

Inovio Pharmaceuticals (INO) Financial Statements

5,707 Followers

Inovio Pharmaceuticals Financial Overview

Inovio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.106; its P/E ratio is -1.33; Inovio Pharmaceuticals is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-1.14. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 100.76K-$ 102.70K$ 388.45K$ 225.97K
Gross Profit$ 100.76K-$ 102.65K$ 388.45K$ 225.97K
EBIT$ -32.24M$ -30.17M$ -24.72M$ -33.62M$ -35.22M
EBITDA$ -31.41M$ -29.41M$ -24.57M-$ -34.08M
Net Income Common Stockholders$ -31.90M$ -30.50M$ -25.00M$ -34.13M$ -35.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 110.42M$ 105.61M$ 145.29M$ 167.47M$ 194.93M
Total Assets$ 133.80M$ 129.11M$ 170.95M$ 193.10M$ 233.04M
Total Debt$ 12.98M$ 13.43M$ 30.21M$ 29.80M$ 30.76M
Net Debt$ -97.44M$ -92.19M$ -115.08M$ -137.67M$ -164.16M
Total Liabilities$ 18.50M$ 34.67M$ 53.60M$ 54.94M$ 63.67M
Stockholders Equity$ 96.74M$ 94.44M$ 117.35M$ 138.16M$ 169.37M
Cash Flow-
Free Cash Flow$ -28.66M$ -28.80M$ -26.13M-$ -32.38M
Operating Cash Flow$ -28.21M$ -28.76M$ -26.28M$ -29.11M$ -32.36M
Investing Cash Flow$ 9.97M$ 45.38M$ 19.94M$ -5.49M$ 53.91M
Financing Cash Flow$ 33.03M$ -11.36M$ 1.84M$ 698.63K$ 2.88M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

Inovio Pharmaceuticals Debt to Assets

Inovio Pharmaceuticals Cash Flow

Inovio Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis